Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Luzze

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
PLOS Global Public Health|June 10, 2025
Vaccine wastage rates and attributed factors in rural and urban areas in Uganda: Case of Mukono and Kalungu districtsMackline Ninsiima, Michael Muhoozi, Henry Luzze, et al.
Plos One|September 9, 2017
Positive predictive value and effectiveness of measles case-based surveillance in Uganda, 2012-2015Fred Nsubuga, Immaculate Ampaire, Simon Kasasa, et al.
Plos One|September 22, 2018
Factors that affect immunization data quality in Kabarole District, UgandaFred Nsubuga, Henry Luzze, Immaculate Ampeire, et al.
The Pan African Medical Journal|June 22, 2019
Comparing static and outreach immunization strategies and associated factors in Uganda, Nov-Dec 2016Fred Nsubuga, Steven Ndugwa Kabwama, Immaculate Ampeire, et al.
Health Research Policy and Systems|August 12, 2021
A qualitative study of the development and utilization of health facility-based immunization microplans in UgandaDavid Kaawa Mafigiri, Constance Iradukunda, Catherine Atumanya, et al.
Emerging Infectious Diseases|November 21, 2017
Enhancing Workforce Capacity to Improve Vaccination Data Quality, UgandaKirsten Ward, Kevin Mugenyi, Amalia Benke, et al.
Vaccine|April 3, 2017
Understanding the policy environment for immunization supply chains: Lessons learned from landscape analyses in Uganda and SenegalHenry Luzze, Ousseynou Badiane, El Hadji Mamadou Ndiaye, et al.
Journal of Virology|January 19, 2002
Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneityKalonji R Collins, Miguel E Quiñones-Mateu, Mianda Wu, et al.
BMC Infectious Diseases|June 6, 2013
Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort studyJackson K Mukonzo, Alphonse Okwera, Neoline Nakasujja, et al.
NIHR Open Research|November 3, 2025
Mapping Community Vulnerability to reduced Vaccine Impact in Uganda and Kenya: A spatial Data-driven ApproachRobinah Nalwanga, Agnes Natukunda, Ludoviko Zirimenya, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
PLOS Global Public Health|June 10, 2025
Vaccine wastage rates and attributed factors in rural and urban areas in Uganda: Case of Mukono and Kalungu districtsMackline Ninsiima, Michael Muhoozi, Henry Luzze, et al.
Plos One|September 9, 2017
Positive predictive value and effectiveness of measles case-based surveillance in Uganda, 2012-2015Fred Nsubuga, Immaculate Ampaire, Simon Kasasa, et al.
Plos One|September 22, 2018
Factors that affect immunization data quality in Kabarole District, UgandaFred Nsubuga, Henry Luzze, Immaculate Ampeire, et al.
The Pan African Medical Journal|June 22, 2019
Comparing static and outreach immunization strategies and associated factors in Uganda, Nov-Dec 2016Fred Nsubuga, Steven Ndugwa Kabwama, Immaculate Ampeire, et al.
Health Research Policy and Systems|August 12, 2021
A qualitative study of the development and utilization of health facility-based immunization microplans in UgandaDavid Kaawa Mafigiri, Constance Iradukunda, Catherine Atumanya, et al.
Emerging Infectious Diseases|November 21, 2017
Enhancing Workforce Capacity to Improve Vaccination Data Quality, UgandaKirsten Ward, Kevin Mugenyi, Amalia Benke, et al.
Vaccine|April 3, 2017
Understanding the policy environment for immunization supply chains: Lessons learned from landscape analyses in Uganda and SenegalHenry Luzze, Ousseynou Badiane, El Hadji Mamadou Ndiaye, et al.
Journal of Virology|January 19, 2002
Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneityKalonji R Collins, Miguel E Quiñones-Mateu, Mianda Wu, et al.
BMC Infectious Diseases|June 6, 2013
Influence of efavirenz pharmacokinetics and pharmacogenetics on neuropsychological disorders in Ugandan HIV-positive patients with or without tuberculosis: a prospective cohort studyJackson K Mukonzo, Alphonse Okwera, Neoline Nakasujja, et al.
NIHR Open Research|November 3, 2025
Mapping Community Vulnerability to reduced Vaccine Impact in Uganda and Kenya: A spatial Data-driven ApproachRobinah Nalwanga, Agnes Natukunda, Ludoviko Zirimenya, et al.
Pageof 3